These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6426994)

  • 1. Almitrine bismesylate in congenital central hypoventilation.
    Fleming PJ; Levine MR; Lewis GT; Pauly N
    Eur J Respir Dis Suppl; 1983; 126():307-12. PubMed ID: 6426994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of almitrine bismesylate to stimulate ventilation in congenital central hypoventilation.
    Shannon DC; Sullivan K; Perret L; Kelly DH
    Eur J Respir Dis Suppl; 1983; 126():295-301. PubMed ID: 6586444
    [No Abstract]   [Full Text] [Related]  

  • 3. Central hypoventilation during quiet sleep in two infants.
    Shannon DC; Marsland DW; Gould JB; Callahan B; Todres ID; Dennis J
    Pediatrics; 1976 Mar; 57(3):342-6. PubMed ID: 1256944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A one year double blind follow-up of blood gas tensions and haemodynamics in almitrine bismesylate therapy.
    Préfaut C; Bourgouin-Karaouni D; Ramonatxo M; Michel FB; Macabies J
    Eur Respir J; 1988 Jan; 1(1):41-50. PubMed ID: 2896600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term studies on almitrine bismesylate in COPD patients.
    Bourgouin-Karaouni D; Mercier J; Prefaut C
    Eur J Respir Dis Suppl; 1986; 146():695-701. PubMed ID: 3096767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to almitrine bismesylate in a child with a central alveolar hypoventilation syndrome.
    Newth CJ; Packman S; Bachand RT
    Eur J Respir Dis Suppl; 1983; 126():303-6. PubMed ID: 6586445
    [No Abstract]   [Full Text] [Related]  

  • 7. Ventilatory effects of almitrine bismesylate in congenital central hypoventilation syndrome.
    Oren J; Newth CJ; Hunt CE; Brouillette RT; Bachand RT; Shannon DC
    Am Rev Respir Dis; 1986 Nov; 134(5):917-9. PubMed ID: 3777687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effects of almitrine bismesylate in chronic obstructive pulmonary disease with CO2 retention].
    Xu FP; Cai YY; Niu SF
    Zhonghua Nei Ke Za Zhi; 1990 Aug; 29(8):479-81, 511. PubMed ID: 2128259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern of breathing and gas exchange following oral almitrine bismesylate in patients with chronic obstructive pulmonary disease.
    Stradling JR; Nicholl CG; Cover D; Davies EE; Hughes JM; Pride NB
    Eur J Respir Dis Suppl; 1983; 126():255-64. PubMed ID: 6373340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of almitrine bismesylate in acute respiratory failure.
    Lambropoulos S; Chatzipappas A; Tsekos G; Tsantoulis K
    Eur J Respir Dis Suppl; 1986; 146():657-61. PubMed ID: 3465586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of almitrine bismesylate 100 mg daily for four weeks on respiratory regulation in patients with chronic bronchitis.
    Stanley NN
    Eur J Respir Dis Suppl; 1986; 146():635-9. PubMed ID: 3096763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pulmonary hemodynamic effects of intravenous almitrine in patients with chronic bronchitis and respiratory insufficiency].
    Weitzenblum E; Ehrhart M; Schneider JC; Hirth C; Roegel E
    Bull Eur Physiopathol Respir; 1982; 18(5):765-73. PubMed ID: 6152773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of almitrine and oxygen on ventilation and gas exchange in patients with chronic respiratory insufficiency.
    Hawryłkiewicz I; Jedrzejewska-Makowska M; Górecka D; Zieliński J
    Eur J Respir Dis; 1983 Oct; 64(7):512-6. PubMed ID: 6138276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The first Italian clinical experience with almitrine bismesylate].
    Grassi V; Bottino G; Blasi A; Grassi C
    Rev Mal Respir; 1985; 2 Suppl 1():S53-60. PubMed ID: 2870548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Almitrine bismesylate.
    Tweney J; Howard P
    Z Erkr Atmungsorgane; 1987; 168(3):197-215. PubMed ID: 2890242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of almitrine bismesylate on breathing pattern during hypoxia/hypercapnia in rats and ferrets.
    Austin CA; Wach RA; Bee D; Finlay M; Emery CJ; Suggett AJ; Barer GR
    Clin Exp Pharmacol Physiol; 1987; 14(11-12):837-50. PubMed ID: 2896080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic importance and tolerance of coated 50 mg Vectarion tablets (almitrine bismesylate) at a dosage of 100 mg/day. Study of blood gas, clinical and biological results after a year of long-term treatment].
    Ansquer JC; Bertrand A; Blaive B; Charpin J; Chrétien J; Decroix G; Kalb JC; Lissac J; Michel FB; Morère P
    Rev Mal Respir; 1985; 2 Suppl 1():S61-7. PubMed ID: 2870549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of almitrine bismesylate on arterial blood gases and ventilatory drive in patients with severe chronic airflow obstruction and bilateral carotid body resection.
    de Backer W; Bogaert E; Van Maele R; Vermeire P
    Eur J Respir Dis Suppl; 1983; 126():239-42. PubMed ID: 6426993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Almitrine improves oxygenation when both awake and asleep in patients with hypoxia and carbon dioxide retention caused by chronic bronchitis and emphysema.
    Connaughton JJ; Douglas NJ; Morgan AD; Shapiro CM; Critchley JA; Pauly N; Flenley DC
    Am Rev Respir Dis; 1985 Aug; 132(2):206-10. PubMed ID: 4026044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of almitrine bismesylate on chemosensitivity in patients with chronic airways obstruction.
    Stanley NN; Pieczora JA; Pauly N
    Eur J Respir Dis Suppl; 1983; 126():233-7. PubMed ID: 6426992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.